Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 20:31:32 UTC
Update Date2021-09-26 23:15:56 UTC
HMDB IDHMDB0258783
Secondary Accession NumbersNone
Metabolite Identification
Common NameTelatinib
Description4-[({4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]-N-methylpyridine-2-carboxamide belongs to the class of organic compounds known as pyridinecarboxamides. Pyridinecarboxamides are compounds containing a pyridine ring bearing a carboxamide. Based on a literature review very few articles have been published on 4-[({4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]-N-methylpyridine-2-carboxamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Telatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Telatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
4-(((4-((4-Chlorphenyl)amino)furo(2,3-D)pyridazin-7-yl)oxy)methyl)-N-methylpyridine-2-carboxamideMeSH
Chemical FormulaC20H16ClN5O3
Average Molecular Weight409.83
Monoisotopic Molecular Weight409.0941671
IUPAC Name4-[({4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]-N-methylpyridine-2-carboxamide
Traditional Nametelatinib
CAS Registry NumberNot Available
SMILES
CNC(=O)C1=NC=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=C1
InChI Identifier
InChI=1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25)
InChI KeyQFCXANHHBCGMAS-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as pyridinecarboxamides. Pyridinecarboxamides are compounds containing a pyridine ring bearing a carboxamide.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassPyridines and derivatives
Sub ClassPyridinecarboxylic acids and derivatives
Direct ParentPyridinecarboxamides
Alternative Parents
Substituents
  • Pyridinecarboxamide
  • 2-heteroaryl carboxamide
  • Aniline or substituted anilines
  • Alkyl aryl ether
  • Aminopyridazine
  • Chlorobenzene
  • Halobenzene
  • Aryl chloride
  • Aryl halide
  • Monocyclic benzene moiety
  • Imidolactam
  • Benzenoid
  • Pyridazine
  • Heteroaromatic compound
  • Furan
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Ether
  • Azacycle
  • Carboxylic acid derivative
  • Oxacycle
  • Organohalogen compound
  • Organooxygen compound
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Organochloride
  • Organonitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.79ALOGPS
logP2.98ChemAxon
logS-3.8ALOGPS
pKa (Strongest Acidic)14.28ChemAxon
pKa (Strongest Basic)1.12ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area102.17 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity109.05 m³·mol⁻¹ChemAxon
Polarizability42.01 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+204.01930932474
DeepCCS[M-H]-201.66130932474
DeepCCS[M-2H]-235.5130932474
DeepCCS[M+Na]+210.73930932474
AllCCS[M+H]+194.732859911
AllCCS[M+H-H2O]+192.132859911
AllCCS[M+NH4]+197.032859911
AllCCS[M+Na]+197.732859911
AllCCS[M-H]-192.032859911
AllCCS[M+Na-2H]-191.632859911
AllCCS[M+HCOO]-191.432859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
TelatinibCNC(=O)C1=NC=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=C14717.0Standard polar33892256
TelatinibCNC(=O)C1=NC=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=C13545.2Standard non polar33892256
TelatinibCNC(=O)C1=NC=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=C13933.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Telatinib,1TMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=CC=N1)[Si](C)(C)C3690.7Semi standard non polar33892256
Telatinib,1TMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=CC=N1)[Si](C)(C)C3321.6Standard non polar33892256
Telatinib,1TMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=CC=N1)[Si](C)(C)C5509.5Standard polar33892256
Telatinib,1TMS,isomer #2CNC(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C)C3=C2OC=C3)=CC=N13488.8Semi standard non polar33892256
Telatinib,1TMS,isomer #2CNC(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C)C3=C2OC=C3)=CC=N13265.4Standard non polar33892256
Telatinib,1TMS,isomer #2CNC(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C)C3=C2OC=C3)=CC=N15428.0Standard polar33892256
Telatinib,2TMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C)C3=C2OC=C3)=CC=N1)[Si](C)(C)C3512.8Semi standard non polar33892256
Telatinib,2TMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C)C3=C2OC=C3)=CC=N1)[Si](C)(C)C3191.9Standard non polar33892256
Telatinib,2TMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C)C3=C2OC=C3)=CC=N1)[Si](C)(C)C4696.7Standard polar33892256
Telatinib,1TBDMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=CC=N1)[Si](C)(C)C(C)(C)C3902.5Semi standard non polar33892256
Telatinib,1TBDMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=CC=N1)[Si](C)(C)C(C)(C)C3466.3Standard non polar33892256
Telatinib,1TBDMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C3=C2OC=C3)=CC=N1)[Si](C)(C)C(C)(C)C5530.2Standard polar33892256
Telatinib,1TBDMS,isomer #2CNC(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C(C)(C)C)C3=C2OC=C3)=CC=N13678.6Semi standard non polar33892256
Telatinib,1TBDMS,isomer #2CNC(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C(C)(C)C)C3=C2OC=C3)=CC=N13407.9Standard non polar33892256
Telatinib,1TBDMS,isomer #2CNC(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C(C)(C)C)C3=C2OC=C3)=CC=N15357.8Standard polar33892256
Telatinib,2TBDMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C(C)(C)C)C3=C2OC=C3)=CC=N1)[Si](C)(C)C(C)(C)C3897.6Semi standard non polar33892256
Telatinib,2TBDMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C(C)(C)C)C3=C2OC=C3)=CC=N1)[Si](C)(C)C(C)(C)C3467.5Standard non polar33892256
Telatinib,2TBDMS,isomer #1CN(C(=O)C1=CC(COC2=NN=C(N(C3=CC=C(Cl)C=C3)[Si](C)(C)C(C)(C)C)C3=C2OC=C3)=CC=N1)[Si](C)(C)C(C)(C)C4733.4Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Telatinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-0fi0-5947000000-d67f9161338de5419fc22021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Telatinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID7984603
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]